Is Tumor Size the Best Predictor of Outcome for Papillary Thyroid Cancer?

Author： Cheema Yusra   Repplinger Daniel   Elson Diane   Chen Herbert  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.13, Iss.11, 2006-11, pp. : 1524-1528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is survivin expression nevertheless related to disease outcome in breast cancer?

By Span Paul   Tjan-Heijnen Vivianne   Sweep Fred  

Breast Cancer Research and Treatment, Vol. 103, Iss. 1, 2007-05 ,pp. : 109-109

Springer Publishing Company

Access to resources Recommend Favorite

Should bisphosphonates be utilized in the adjuvant setting for breast cancer?

By Lipton Allan  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 627-636

Springer Publishing Company

Access to resources Recommend Favorite

Hypothesis: Does ochratoxin A cause testicular cancer?

By Schwartz G.G.  

Cancer Causes and Control, Vol. 13, Iss. 1, 2002-02 ,pp. : 91-100

Springer Publishing Company

Access to resources Recommend Favorite

Hypothesis: is antibiotic use associated with breast cancer?

By Velicer Christine M.  

Cancer Causes and Control, Vol. 14, Iss. 8, 2003-01 ,pp. : 739-747

Springer Publishing Company

Access to resources Recommend Favorite

Breath test: a new diagnostic tool for colorectal cancer?

By Altomare Donato F   Lena Maria Di   Travaglio Elisabetta  

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 91-93

Future Medicine

Access to resources Recommend Favorite